Microrna In Disease Regulation
46 researchers across 5 institutions
Research in this area investigates the role of microRNAs (miRNAs) in regulating biological processes and their implications in various diseases. Scientists examine how these small RNA molecules function as key regulators of gene expression, influencing cellular pathways involved in development, differentiation, and disease pathogenesis. Studies employ molecular biology techniques, bioinformatics, and advanced imaging to identify and characterize specific miRNAs associated with conditions such as cancer, cardiovascular disease, and neurological disorders. Investigations also explore the potential of miRNAs as diagnostic biomarkers and therapeutic targets.
This work holds significant relevance for Arkansas by addressing public health challenges and supporting the state's growing biosciences sector. Understanding miRNA dysregulation in diseases prevalent in the region, like certain cancers and metabolic disorders, can inform the development of new diagnostic tools and treatment strategies. Furthermore, research into environmental exposures and their impact on miRNA expression contributes to understanding potential health risks and safeguarding public well-being.
This field draws on expertise from molecular biology, genetics, bioinformatics, and toxicology. The research is conducted across multiple institutions in Arkansas, fostering collaboration and leveraging diverse strengths in experimental design and data analysis. Connections are made to related areas including cancer mechanisms, epigenetics, and pharmacological studies.
Top Researchers
| Name | Institution | h-index | Citations | Career Stage | Badges |
|---|---|---|---|---|---|
| Igor P. Pogribny | NCTR | 76 | 18,238 | ARA High Impact | |
| Volodymyr Tryndyak | NCTR | 44 | 7,008 | High Impact | |
| Xinyu Li | University of Arkansas | 43 | 5,893 | High Impact | |
| Gang� Li | UAMS | 38 | 5,080 | High Impact | |
| Zhiqiang Qin | UAMS | 35 | 3,809 | Faculty | Grant PI High Impact |
| Gohar Azhar | UAMS | 33 | 3,220 | High Impact | |
| Beverly D. Lyn‐Cook | NCTR | 30 | 3,206 | High Impact | |
| Wei Zhao | UA Little Rock | 30 | 3,154 | Faculty | |
| Tyrone A. Washington | University of Arkansas | 27 | 2,190 | Faculty | Grant PI High Impact |
| George Hammons | NCTR | 24 | 2,057 | ||
| Ryan M. Allen | UAMS | 20 | 2,301 | Faculty | Grant PI High Impact |
| Dongying Li | NCTR | 20 | 1,228 | ||
| Donghoon Yoon | UAMS | 18 | 1,272 | Faculty | |
| Patricia Porter‐Gill | UAMS | 18 | 2,038 | ||
| Ruofei Du | UAMS | 16 | 826 | Faculty | |
| Svitlana Shpyleva | NCTR | 16 | 1,449 | ||
| Neha S. Dole | UAMS | 14 | 634 | Faculty | Grant PI |
| Ana Clara P. Azevedo‐Pouly | UAMS | 13 | 790 | ||
| Shan Zhao | University of Arkansas | 13 | 790 | ||
| Hoda A. Hagrass | UAMS | 12 | 510 | Faculty |
Related Research Areas
Strategic Outlook
Global signals from OpenAlex for this research area: where the field is growing, how concentrated leadership is, and where Arkansas sits relative to the world's top-100 institutions. Descriptive only — surfaced as input to the conversation about where to place bets, not a recommendation. Signal confidence: LOW
Top US institutions in this area
- 1 Harvard University 2,559
- 2 The University of Texas MD Anderson Cancer Center 1,710
- 3 The Ohio State University 1,371
- 4 National Institutes of Health 1,185
- 5 Johns Hopkins University 1,166
Cross-Institution Connections
Researchers at different institutions with overlapping expertise in Microrna In Disease Regulation.